Irritable Bowel Syndrome: New Agents Targeting Serotonin Receptor Subtypes

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.3, 2001-01, pp. : 317-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review

Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. : 1774-1781

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational agents for the irritable bowel syndrome

By Ghaith Ola El-Halabi Mustapha Hashash Jana G Sharara Ala I

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1161-1178

Informa Healthcare

Access to resources Recommend Favorite

Probiotic Agents in the Treatment of Irritable Bowel Syndrome

By Guslandi M

The Journal of International Medical Research, Vol. 35, Iss. 5, 2007-09 ,pp. : 583-589

Field House Publishing

Access to resources Recommend Favorite

New Drugs in the Management of the Irritable Bowel Syndrome

By Farthing M.J.G.

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 11-21

Adis International

Access to resources Recommend Favorite

Alosetron and irritable bowel syndrome

By Mayer Emeran A Bradesi Sylvie

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2089-2098

Informa Healthcare

Access to resources Recommend Favorite